Correction: The application of CRISPR/Cas9 system in cervical carcinogenesis

Chun Gao^#^{1

2}, Ping Wu^#^{1

2}, Lan Yu^#³, Liting Liu¹, Hong Liu¹, Xiangyu Tan¹, Liming Wang^{1

2}, Xiaoyuan Huang^{4

5}, Hui Wang^{6

7

8}

Affiliations

¹ Cancer Biology Research Center (Key laboratory of the ministry of education), Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
² Department of Gynecologic Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
³ Department of Gynecologic Oncology, Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.
⁴ Cancer Biology Research Center (Key laboratory of the ministry of education), Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China. huangxy@tjh.tjmu.edu.cn.
⁵ Department of Gynecologic Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China. huangxy@tjh.tjmu.edu.cn.
⁶ Cancer Biology Research Center (Key laboratory of the ministry of education), Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China. wang71hui@aliyun.com.
⁷ Department of Gynecologic Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China. wang71hui@aliyun.com.
⁸ Department of Gynecologic Oncology, Women's Hospital, School of Medicine, Zhejiang University, Zhejiang, China. wang71hui@aliyun.com.

^# Contributed equally.

Published Erratum

Chun Gao et al. Cancer Gene Ther. 2022 May.

. 2022 May;29(5):625-626.

doi: 10.1038/s41417-021-00393-7.

Chun Gao^#^{1

2}, Ping Wu^#^{1

2}, Lan Yu^#³, Liting Liu¹, Hong Liu¹, Xiangyu Tan¹, Liming Wang^{1

2}, Xiaoyuan Huang^{4

5}, Hui Wang^{6

7

8}

¹ Cancer Biology Research Center (Key laboratory of the ministry of education), Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
² Department of Gynecologic Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
³ Department of Gynecologic Oncology, Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.
⁴ Cancer Biology Research Center (Key laboratory of the ministry of education), Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China. huangxy@tjh.tjmu.edu.cn.
⁵ Department of Gynecologic Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China. huangxy@tjh.tjmu.edu.cn.
⁶ Cancer Biology Research Center (Key laboratory of the ministry of education), Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China. wang71hui@aliyun.com.
⁷ Department of Gynecologic Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China. wang71hui@aliyun.com.
⁸ Department of Gynecologic Oncology, Women's Hospital, School of Medicine, Zhejiang University, Zhejiang, China. wang71hui@aliyun.com.

^# Contributed equally.

No abstract available

Figures

The application of CRISPR/Cas9 system in cervical carcinogenesis.
Gao C, Wu P, Yu L, Liu L, Liu H, Tan X, Wang L, Huang X, Wang H. Gao C, et al. Cancer Gene Ther. 2022 May;29(5):466-474. doi: 10.1038/s41417-021-00366-w. Epub 2021 Aug 4. Cancer Gene Ther. 2022. PMID: 34349239 Free PMC article.